Abstract
BackgroundType I interferon (IFN-I) is strongly implicated in the pathogenesis of Systemic Lupus Erythematosus (SLE) and “interferonopathies” such as Aicardi-Goutieres Syndrome (AGS). A recently discovered DNA-activated IFN-I pathway, cyclic GMP-AMP...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
